Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126116731 | 12611673 | 1 | I | 2006 | 20141011 | 20160801 | 20160801 | EXP | US-TAKEDA-2014TUS007259 | TAKEDA | 0.00 | Y | 0.00000 | 20160801 | LW | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126116731 | 12611673 | 1 | PS | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | Oral | UNK | U | 21073 | TABLET | ||||||||
| 126116731 | 12611673 | 2 | SS | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | Oral | UNK | U | 21073 | TABLET | ||||||||
| 126116731 | 12611673 | 3 | SS | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | Oral | UNK | U | 21073 | TABLET | ||||||||
| 126116731 | 12611673 | 4 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 126116731 | 12611673 | 5 | C | REZULIN | TROGLITAZONE | 1 | UNK | U | 0 | ||||||||||
| 126116731 | 12611673 | 6 | C | GLUCOTROL | GLIPIZIDE | 1 | 10 MG, BID | U | 0 | 10 | MG | BID | |||||||
| 126116731 | 12611673 | 7 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | UNK | U | 0 | ||||||||||
| 126116731 | 12611673 | 8 | C | JANUMET | METFORMIN HYDROCHLORIDESITAGLIPTIN PHOSPHATE | 1 | 50 MG, BID | U | 0 | 50 | MG | BID | |||||||
| 126116731 | 12611673 | 9 | C | JANUMET | METFORMIN HYDROCHLORIDESITAGLIPTIN PHOSPHATE | 1 | 1000 MG, BID | U | 0 | 1000 | MG | BID | |||||||
| 126116731 | 12611673 | 10 | C | WELCHOL | COLESEVELAM HYDROCHLORIDE | 1 | 3.75 G, QD | U | 0 | 3.75 | G | QD | |||||||
| 126116731 | 12611673 | 11 | C | AZOR | AMLODIPINE BESYLATEOLMESARTAN MEDOXOMIL | 1 | 10 MG, QD | U | 0 | 10 | MG | QD | |||||||
| 126116731 | 12611673 | 12 | C | AZOR | AMLODIPINE BESYLATEOLMESARTAN MEDOXOMIL | 1 | 40 MG, QD | U | 0 | 40 | MG | QD | |||||||
| 126116731 | 12611673 | 13 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | 20 MG | U | 0 | 20 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126116731 | 12611673 | 1 | Type 2 diabetes mellitus |
| 126116731 | 12611673 | 8 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126116731 | 12611673 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126116731 | 12611673 | Abscess | |
| 126116731 | 12611673 | Bladder cancer |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126116731 | 12611673 | 1 | 2006 | 0 | ||
| 126116731 | 12611673 | 2 | 2007 | 0 | ||
| 126116731 | 12611673 | 3 | 2008 | 0 |